Moderna Inc (MRNA)

$117.31 5.38 (4.39%)

16:00 EDT MRNA Stock Quote Delayed 30 Minutes

Just Say No to Drugs: 3 Pharma Stocks to Avoid

By Shane Neagle, InvestorPlace Contributor May 8, 2024

Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios.

Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar

MRNA Stock Earnings: Moderna Beats EPS, Beats Revenue for Q1 2024

Stock Market Crash Warning: Don’t Get Caught Holding These 3 Cathie Wood Stocks

Volume:

Previous Close -

Market Cap 44.93B

PE Ratio -7.49

EPS -15.66

Volume (Avg. Vol.) 4.24M

Day's Range $116.73 - $124.90

52-Week Range $62.55 - $142.79

Dividend & Yield N/A (N/A)

MRNA Stock Predictions, Articles, and Moderna Inc News

From InvestorPlace
From the Web

Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar

By Joey Frenette, InvestorPlace Contributor May 1, 2024

These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May.

3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition

By Chandler Capital, InvestorPlace Contributor Apr 30, 2024

Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future.

Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy

By Josh Enomoto, InvestorPlace Contributor Apr 23, 2024

While artificial intelligence may be useful for a variety of purposes – including asking silly questions we’re afraid to pose in real life – the…

3 Pharma Stocks to Sell in April Before They Crash & Burn

By Matthew Farley, InvestorPlace Contributor Apr 11, 2024

Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside.

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

By Muslim Farooque, InvestorPlace Contributor Apr 11, 2024

Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

By Andy Kim, InvestorPlace Contributor Apr 5, 2024

The healthcare industry is one of the most potent yet also one of the most competitive. This has short sellers out for blood.

The 3 Most Undervalued Biotech Stocks to Buy in April 2024

By Joey Frenette, InvestorPlace Contributor Apr 5, 2024

The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast impressive pipelines.

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition

By Shane Neagle, InvestorPlace Contributor Mar 28, 2024

Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.

3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise

By Matthew Farley, InvestorPlace Contributor Mar 15, 2024

Dive into the potential of precision medicine stocks poised to revolutionize healthcare and offer substantial growth opportunities.

Turnaround Plays: 3 Stocks to Buy for a Major Recovery in 2024

By Joel Baglole, InvestorPlace Contributor Mar 8, 2024

While most companies that change their plans fail, investors should pay attention to these three turnaround stocks poised for recovery.

3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise

By Shane Neagle, InvestorPlace Contributor Mar 7, 2024

Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth.

7 F-Rated Stocks to Sell in March 2024

By Louis Navellier and the InvestorPlace Research Staff Mar 7, 2024

This market is too strong to risk holding F-rated stocks. If you're still seeing these names in your portfolio, it's time to make a move.

It’s Time! 3 Failing Biotech Stocks to Sell Right Now

By Noah Bolton, InvestorPlace Contributor Mar 5, 2024

The biotech industry offers investors unique investment opportunities but these three are biotechs to sell.

ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential

By Viktor Zarev, InvestorPlace Contributor Mar 4, 2024

Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential.

Earnings Seasons Score Card: 4 Stock Superstars and 3 That Fell Short

By Joel Baglole, InvestorPlace Contributor Feb 28, 2024

In recent weeks, stocks have risen and fallen dramatically based on the financial results of the companies behind them. Investor portfolios have been violently jostled by the prints, many of which surprised people on both Wall Street and Main Street.

Looming Layoffs? 3 Companies That May Be the Next to Drop the Axe.

By Will Ashworth, InvestorPlace Contributor Feb 19, 2024

Layoffs were a big theme in 2023. Unless the economy drastically picks up in 2024, they could happen this year in large numbers.

ChatGPT Stock Predictions: 3 Companies the AI Bot Thinks Have 10X Potential

By Faizan Farooque, InvestorPlace Contributor Feb 14, 2024

Navigate the stock market with confidence using AI stock predictions. Harness the latest in AI technology for strategic investment planning.

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024

By Muslim Farooque, InvestorPlace Contributor Feb 11, 2024

Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly.

7 Stocks to Sell as Fast as You Possibly Can

By Louis Navellier and the InvestorPlace Research Staff Feb 8, 2024

Don't be nostalgic about these. Dumping each of these stocks to sell now will go a long way toward saving your portfolio.

3 Stocks Poised to Bounce Back After a Brutal 2023

By Joel Baglole, InvestorPlace Contributor Jan 18, 2024

These companies, which badly lagged the market last year, now look to be turning things around and could be rebound stocks in the year ahead.

Moderna Inc (MRNA)

Just Say No to Drugs: 3 Pharma Stocks to Avoid

Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar

MRNA Stock Earnings: Moderna Beats EPS, Beats Revenue for Q1 2024

Stock Market Crash Warning: Don’t Get Caught Holding These 3 Cathie Wood Stocks

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Moderna Inc (MRNA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRNA Stock Predictions, Articles, and Moderna Inc News

Subscriber Sign in